|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Histamine and Hrantihistamines: celebrating a century of progress 显示文摘 | Simons FE Simons KJ | 2011 | J Allergy Clin Immunol2011，128，6： | 1 |
| 2 | World Allergy Organization anaphylaxis guidelines:summary显示文摘 | Simons FE Ardusso LR Bilò MB | | 0，，03： | 1 |
| 3 | World allergy organization guidelines for the assessment and management of anaphylaxis显示文摘 | Simons FE Ardusso LR Bilo MB | 2011 | World Allergy Organ J2011，4，2： | 1 |
| 4 | World allergy organization guidelines for the assessment and management of anaphylaxis 显示文摘 | Simons FE Ardusso LR Bilb MB | 2011 | World Allergy Organ J2011，4，2： | 1 |
| 5 | Mizolastine:antihistaminic activity from preclinical data to clinical evaluation 显示文摘 | Simons FE | 1999 | Clin Exp Allergy1999，29，1： | 1 |
| 6 | Clinical pharmacology of new histamine H1 receptor antagonists显示文摘 | Simons FE Simons KJ | 1999 | Clin Pharmacokinet1999，36，5： | 1 |
| 7 | Risk as- sessment in anaphylaxis: current and future approach- es显示文摘 | Simons FE Frew A J Ansotegui IJ | 2007 | J Allergy C lin Immunol2007，120，1： | 1 |
| 8 | Anaphylaxis显示文摘 | Simons FE | 2010 | J Allergy Clin Immunol2010，125，2： | 1 |
| 9 | H1-antihistamines in children 显示文摘 | | 2002 | Clin Allergy Immunol2002，17，： | 1 |
| 10 | Mizolastine: antihistaminic activity from preclinical data to clinical evaluation显示文摘 | Simons FE | 1999 | Clin Exp Allergy1999，291，： | 1 |
| 11 | World allergy organization anaphylaxis guidelines: 2013 update of the evidence base显示文摘 | Simons FE Ardusso LR Dimov V | 2013 | Int Arch Allergy Immunol2013，162，3： | 1 |
| 12 | Safety of levocetirizine treatment in young atopic children: an 18-month study 显示文摘 | Simons FE | 2007 | Pediatr Allergy Immunol2007，18，6： | 1 |
| 13 | A double-blind, singledose, crossover comparison of cetirizine, terfenadine, loratadine,astemizole, and chlorpheniramine versus placebo: Suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects显示文摘 | McMillan JL Simons KJ | 1990 | J Allergy Clin Immunol1990，86，41： | 1 |
| 14 | Sublingual allergen immunotherapy:mode of action and its relationship with the safety profile显示文摘 | Calderón MA Simons FE Malling HJ | | 0，，03： | 1 |
| 15 | Suppression of early and late cutaneous allergic response using fexofenadine and montelukast 显示文摘 | Simons FE Johnston L Gu X | 2001 | Ann Allergy Asthmia Immunol2001，86，： | 1 |
| 16 | H1-antihistamines in children显示文摘 | Simons FE | 2002 | Clin Allergy Immunol2002，17，8： | 1 |
| 17 | Montelukast added to budesonide in children with persistent asthma:a randomized,double-blind,cross over study显示文摘 | Simons FE Villa JR Lee BW | 2001 | J Pediatr2001，138，5： | 1 |
| 18 | Consensus Group on New-Generation Antihistamines(CONGA):present status and recommendations显示文摘 | Holgate ST Canonica GW Simons FE | 2003 | Clin Exp Allergy2003，33，9： | 1 |
| 19 | A double-blind,singledose,crossover comparison of cetirizine,terfenadine,lratadine,astemizole,and chlorphcniramine versus placebo:Suppressive effects on histamine-induced wheals and flares during 24hours in normal subjects显示文摘 | Simons FE McMillan JL Simons KJ | 1990 | J Allergy Clin Immunol1990，86，41： | 1 |
| 20 | A double- blind, single- dose, crossover comparison of eetirizine, terfenadine, loratadine, astemizole and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal suhiects显示文摘 | Simons FE McMillan JL Simons KJ | 1990 | J Allergy Clin Immunol1990，86，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员